Database→Thymosin Alpha-1

Tier 1–2ImmuneAnti-inflammatoryAnti-agingPREMIUM

Thymosin Alpha-1

Thymosin Alpha-1 (Thymalfasin / Zadaxin / Tα1)

Approved in 35+ countries (Zadaxin/Thymalfasin) for hepatitis B/C and immune enhancement. Research compound in the USA with no FDA approval. Not listed on 2026 WADA Prohibited List.

For research and educational purposes only · Not medical advice · Consult a qualified physician before any human use

Profile Overview

Thymosin Alpha-1 is the most extensively human-studied peptide in this research series: 30+ clinical trials, 11,000+ subjects, and regulatory approvals in 35+ countries. It modulates the immune system via TLR-2/TLR-9 activation to enhance T-cell differentiation and Th1 polarization. Strongest current applications are vaccine adjuvancy in elderly/immunocompromised patients and cancer combination immunotherapy regimens.

🔒

Full Profile: Premium Members Only

The complete Thymosin Alpha-1 profile includes all use cases with full evidence reviews, mechanism of action deep dive, safety analysis, evidence table, dosing guidance, and stack compatibility data.

For research and educational purposes only · Not medical advice · Consult a qualified physician before any human use